{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:10:50Z","timestamp":1781269850735,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1092856"],"award-info":[{"award-number":["APP 1092856"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41431-019-0390-9","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T17:03:17Z","timestamp":1554742997000},"page":"1186-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of telephone genetic counselling to facilitate germline BRCA1\/2 testing in women with high-grade serous ovarian cancer"],"prefix":"10.1038","volume":"27","author":[{"given":"Erin","family":"Tutty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3245-8895","authenticated-orcid":false,"given":"Lara","family":"Petelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Anne","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Meiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Forbes Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-4657","authenticated-orcid":false,"given":"Paul A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-4971","authenticated-orcid":false,"given":"Laura E.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrclinonc.2016.191","volume":"14","author":"A George","year":"2017","unstructured":"George A, Kaye S, Banerjee S. Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer. Nat Rev Clin Oncol. 2017;14:284.","journal-title":"Nat Rev Clin Oncol"},{"key":"390_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C. BRCA mutation frequency and patterns of treatment response in BRCA mutation\u2013positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J of Clin Onc. 2012;30:2654.","journal-title":"J of Clin Onc"},{"key":"390_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jmedgenet-2016-103902","volume":"53","author":"I Plaskocinska","year":"2016","unstructured":"Plaskocinska I, Shipman H, Drummond J, Thompson E, Buchanan V, Newcombe B, et al. New paradigms for BRCA1\/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study. J Med Genet. 2016;53:655\u201361.","journal-title":"J Med Genet"},{"key":"390_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ygyno.2011.09.040","volume":"124","author":"B Meiser","year":"2012","unstructured":"Meiser B, Gleeson M, Kasparian N, Barlow-Stewart K, Ryan M, Watts K, et al. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer. Gynecol Oncol. 2012;124:153\u20137.","journal-title":"Gynecol Oncol"},{"key":"390_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:29506.","journal-title":"Sci Rep"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2015.04.029","volume":"138","author":"T Febbraro","year":"2015","unstructured":"Febbraro T, Robison K, Wilbur JS, Laprise J, Bregar A, Lopes V, et al. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Gynecol Oncol. 2015;138:109\u201314.","journal-title":"Gynecol Oncol"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/ejhg.2016.95","volume":"24","author":"N Hoogerbrugge","year":"2016","unstructured":"Hoogerbrugge N, Jongmans MCJ. Finding all BRCA pathogenic mutation carriers: best practice models. Eur J Hum Genet. 2016;24:S19.","journal-title":"Eur J Hum Genet"},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, Defazio A, Emmanuel C, George J, et al. BRCA Mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30:2654\u201363.","journal-title":"J Clin Oncol"},{"key":"390_CR9","unstructured":"eviQ. Genetic testing for heritable mutations in the BRCA1 and BRCA2 genes. V.6 ed: Cancer Institute NSW; 2018."},{"key":"390_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ejhg.2014.86","volume":"23","author":"A Crook","year":"2015","unstructured":"Crook A, Plunkett L, Forrest LE, Hallowell N, Wake S, Alsop K, et al. Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS). Eur J Hum Genet. 2015;23:152\u20138.","journal-title":"Eur J Hum Genet"},{"key":"390_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:29506.","journal-title":"Sci Rep"},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/A:1009437308575","volume":"9","author":"V Wang","year":"2000","unstructured":"Wang V. Commentary: What is and is not telephone counseling? J Genet Couns. 2000;9:73\u201382.","journal-title":"J Genet Couns"},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/A:1009433224504","volume":"9","author":"KE Ormond","year":"2000","unstructured":"Ormond KE, Haun J, Cook L, Duquette D, Ludowese C, Matthews AL. Recommendations for telephone counseling. J Genet Couns. 2000;9:63\u201371.","journal-title":"J Genet Couns"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1022663324006","volume":"12","author":"KK Sangha","year":"2003","unstructured":"Sangha KK, Dircks A, Langlois S. Assessment of the effectiveness of genetic counseling by telephone compared to a clinic visit. J Genet Couns. 2003;12:171\u201384.","journal-title":"J Genet Couns"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","volume":"32","author":"MD Schwartz","year":"2014","unstructured":"Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang A-T, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014;32:618\u201326.","journal-title":"J Clin Oncol"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"dju328","DOI":"10.1093\/jnci\/dju328","volume":"106","author":"AY Kinney","year":"2014","unstructured":"Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, et al. Expanding access to BRCA1\/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst. 2014;106:dju328.","journal-title":"J Natl Cancer Inst."},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"pkx002","DOI":"10.1093\/jncics\/pkx002","volume":"1:","author":"MK Interrante","year":"2017","unstructured":"Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, et al. Randomized noninferiority trial of telephone vs in-person genetic counseling for hereditary breast and ovarian cancer: a 12-month follow-up. JNCI Cancer Spectrum. 2017;1:pkx002.","journal-title":"JNCI Cancer Spectrum"},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1200\/JCO.2015.65.9557","volume":"34","author":"AY Kinney","year":"2016","unstructured":"Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee J-H, et al. Randomized noninferiority trial of telephone delivery of BRCA1\/2 genetic counseling compared with in-person counseling: 1-year follow-up. J Clin Oncol. 2016;34:2914.","journal-title":"J Clin Oncol"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/gim.2014.125","volume":"17","author":"M Butrick","year":"2014","unstructured":"Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, et al. Disparities in uptake of BRCA1\/2 genetic testing in a randomized trial of telephone counseling. Genet Med. 2014;17:467.","journal-title":"Genet Med"},{"key":"390_CR20","first-page":"143","volume":"13","author":"AS Sie","year":"2014","unstructured":"Sie AS, van Zelst-Stams WAG, Spruijt L, Mensenkamp AR, Ligtenberg MJL, Brunner HG, et al. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Fam Cancer. 2014;13:143\u201351.","journal-title":"Fam Cancer"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/bmj.288.6428.1470","volume":"288","author":"RJ Maxwell","year":"1984","unstructured":"Maxwell RJ. Quality assessment in health. Br Med J. 1984;288:1470. Clin ResEd","journal-title":"Br Med J"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor Robert, Thielke Robert, Payne Jonathon. Nathaniel Gonzalez, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"390_CR23","unstructured":"World Bank WDI. Consumer price index (2010\u2009=\u2009100) 2018 [Available from: \n                    https:\/\/data.worldbank.org\/indicator\/fp.cpi.totl\n                    \n                  ."},{"key":"390_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1037\/0278-6133.21.6.564","volume":"21","author":"D Cella","year":"2002","unstructured":"Cella D, Hughes C, Peterman A, Chang C-H, Peshkin BN, Schwartz MD, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol. 2002;21:564.","journal-title":"Health Psychol"},{"key":"390_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10897-015-9897-6","volume":"25","author":"BN Peshkin","year":"2016","unstructured":"Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, et al. Patient perceptions of telephone vs. in-person BRCA1\/BRCA2 genetic counseling. J Genet Couns. 2016;25:472\u201382.","journal-title":"J Genet Couns"},{"key":"390_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1369-6513.2001.00140.x","volume":"4","author":"Theresa M. Marteau","year":"2001","unstructured":"Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health expect. 2001;4:99\u2013108.","journal-title":"Health Expectations"},{"key":"390_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"Jamie C. Brehaut","year":"2016","unstructured":"Brehaut J, O'Connor A, Wood T, Hack T, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Making. 2003;23:281\u201392.","journal-title":"Medical Decision Making"},{"key":"390_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1192\/bjp.180.3.205","volume":"180","author":"EC Sundin","year":"2002","unstructured":"Sundin EC, Horowitz MJ. Impact of Event Scale: psychometric properties. Br J Psychiatry. 2002;180:205\u20139.","journal-title":"Br J Psychiatry"},{"key":"390_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10897-014-9713-8","volume":"23","author":"AM Elliott","year":"2014","unstructured":"Elliott AM, Chodirker BN, Bocangel P, Mhanni AA. Evaluation of a clinical genetics service\u2013a quality initiative. J Genet Couns. 2014;23:881\u20139.","journal-title":"J Genet Couns"},{"key":"390_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/B:JOGC.0000035523.96133.bc","volume":"13","author":"TA DeMarco","year":"2004","unstructured":"DeMarco TA, Peshkin BN, Mars BD, Tercyak KP. Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. J Genet Couns. 2004;13:293\u2013304.","journal-title":"J Genet Couns"},{"key":"390_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ajmg.a.30577","volume":"134A","author":"C Wang","year":"2005","unstructured":"Wang C, Gonzalez R, Milliron K, Strcher V, Merajver S. Genetic counseling for BRCA1\/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. Am J Med Genet. 2005;134A:66\u201373.","journal-title":"Am J Med Genet"},{"key":"390_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood AM, Dunn G, Shiloh S, Todd C. The Genetic Counseling Outcome Scale: a New patient\u2010reported outcome measure for clinical genetics services. Clin Genet. 2011;79:413\u201324.","journal-title":"Clin Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0390-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:59:42Z","timestamp":1684616382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-019-0390-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1038\/s41431-019-0390-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"3 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Bettina Meiser has a remunerated consultant role with the company Astrazeneca with respect to an unrelated project. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}